Stockholders' Equity

3 Months Ended

Jan. 31, 2025

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Note 9. Stockholders' Equity

Analysis of Changes in Accumulated Other Comprehensive Loss:

(In millions)	Foreign Currency Translation Adjustment		Minimum Pension Liability		Derivative Instruments		Total
Balance at October 31, 2023	$	(538.0)	$	(3.2)	$	87.4	$	(453.8)
Gross change in value	59.8		—		(36.8)		23.0
Tax effect	—		—		8.8		8.8
Balance at January 31, 2024	$	(478.2)	$	(3.2)	$	59.4	$	(422.0)
Balance at October 31, 2024	$	(461.7)	$	(4.9)	$	44.9	$	(421.7)
Gross change in value	(66.7)		—		(2.5)		(69.2)
Tax effect	—		—		0.5		0.5
Balance at January 31, 2025	$	(528.4)	$	(4.9)	$	42.9	$	(490.4)

Share Repurchases

In March 2017, the authorization under the 2012 Share Repurchase Program was increased to $1.0 billion by the Company's Board of Directors. As of January 31, 2025, $256.4 million remains authorized for repurchase.

During the three months ended January 31, 2025 and 2024, there were no share repurchases.

Dividends    

In December 2023, the Company's Board of Directors decided to end the declaration of a semiannual dividend.